HHS performs world-first exosome burn treatment
Analysis based on 6 articles · First reported Jun 15, 2026 · Last updated Jun 15, 2026
This medical breakthrough by Hamilton Health Sciences could significantly impact the biotechnology and healthcare industries by introducing a novel and highly effective burn treatment. Companies involved in exosome research and development may see increased interest and investment, potentially leading to new product development and improved patient outcomes globally. The success of this treatment could also influence healthcare policies and standards of care for burn victims, potentially reducing the need for traditional skin grafting procedures.
Hamilton Health Sciences (HHS) burn experts, led by Dr. Marc Jeschke, have performed the world's first exosome treatment on a severely burned patient, Kaitlin Jeffrey, in London, Ontario. This innovative biological treatment, which uses exosomes to accelerate healing and reduce inflammation, was approved by Canada — Health Canada on compassionate grounds. The treatment resulted in faster healing and better cosmetic outcomes for Kaitlin Jeffrey compared to traditional skin grafting, offering a promising new standard of care for burn patients in Canada and potentially worldwide. Dr. Jeschke, also a professor at McMaster University, hopes this therapy will become a new standard.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard